Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$1.9M
+91.7% from 2023
Prescriptions
837
$2,225.06 per claim
Patients
198
167 prescribers
Total spending, 2024
$1.9M
$9,405.93 per patient
Medicare prescription drug plans paid $1.9M for Amphotericin B Liposome in 2024, for 837 prescriptions and refills to 198 patients (up 91.7% from 2023). The average cost per claim was $2,225.06.
New Jersey had the highest Medicare cost for Amphotericin B Liposome in 2024: $330K for 47 claims, followed by California ($313K).
Madhu Suryadevara, infectious disease in Newark, NJ, had the highest Medicare cost for Amphotericin B Liposome in 2024: 32 claims costing $224K.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Madhu Suryadevara Newark, NJ | Infectious Disease | 32 | Under 11 | $224K |
| Saurabh Kapoor Englewood, NJ | Cardiology | 15 | Under 11 | $106K |
| Stephen S Weigt |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 47 | 107 | 48 | $371K |
| 2023 | 124 | 381 | 142 | $971K |
| 2024 | 167 | 837 | 198 | $1.9M |
Spending by manufacturer as listed in the spending data
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Pulmonary Disease |
| 16 |
| Under 11 |
| $58K |
| Ji Hoon Baang Los Angeles, CA | Infectious Disease | 28 | Under 11 | $53K |
| Ramachandra R Sista Phoenix, AZ | Pulmonary Disease | 12 | Under 11 | $51K |
| Naureen Narula Lexington, KY | Pulmonary Disease | 11 | Under 11 | $45K |
| Erin M Lowery Madison, WI | Pulmonary Disease | 11 | Under 11 | $43K |
| Adil Sheikh Boston, MA | Pulmonary Disease | 11 | Under 11 | $29K |
| Srinivas Bollineni Dallas, TX | Pulmonary Disease | 47 | Under 11 | $28K |
| Omer E Beaird Los Angeles, CA | Infectious Disease | 50 | Under 11 | $25K |
| Mark W Rolfe Oklahoma City, OK | Pulmonary Disease | 15 | Under 11 | $19K |
| Louis M Emmer Staten Island, NY | Internal Medicine | 15 | Under 11 | $17K |
| Manish R Mohanka Dallas, TX | Pulmonary Disease | 23 | Under 11 | $14K |
| Ami J Perry Oklahoma City, OK | Nurse Practitioner | 15 | Under 11 | $13K |
| James P Gagermeier Maywood, IL | Pulmonary Disease | 11 | Under 11 | $11K |
| Bruce Johnson Pittsburgh, PA | Pulmonary Disease | 13 | Under 11 | $9,209 |
| Heriberto Garcia Dallas, TX | Nurse Practitioner | 13 | Under 11 | $9,007 |
| Chelsea L Petro Dallas, TX | Physician Assistant | 13 | Under 11 | $8,303 |
| Adrian C Lawrence Dallas, TX | Pulmonary Disease | 11 | Under 11 | $6,628 |
| Heather M Strah Omaha, NE | Pulmonary Disease | 13 | Under 11 | $6,200 |
| Monica V Esquivel San Antonio, TX | Nurse Practitioner | 25 | Under 11 | $5,119 |
| Holly Keyt San Antonio, TX | Critical Care (Intensivists) | 12 | Under 11 | $2,535 |
| Craig Dockter Mobridge, SD | Optometry | 43 | Under 11 | $1,284 |
| Manufacturer | Claims | Spending |
|---|---|---|
| Sun Pharmaceuti SUNPHARMA.NS | 610 | $1.3M |
| Eugia US LLC | 227 | $527K |